Graphic of a fountain pen writing on a piece of paper
The Pharmaceutical Research and Manufacturers of America (PhRMA) today called on the Office of the United States Trade Representative (USTR) to defend American biopharmaceutical innovators and jobs by ending market access and intellectual property barriers in 24 leading economies around the world. In its submission for USTR’s 2020 Special 301 Report, PhRMA called on the Trump administration to address discriminatory market access practices abroad that free ride on American innovation and put U.S. jobs and exports at risk.
Graphic of a fountain pen writing on a piece of paper

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.